The tweet was deleted by the author.
But we saved everything 🙂.
Altimmune has announced the appointment of Luis Sanay as vice president of investor relations. The company expects Sanay, who brings 15 years of experience in investor relations and financial communications across the biotechnology and pharmaceutical sectors, to provide valuable insight as Altimmune continues its work on treatments for serious liver diseases.
Sanay’s appointment underscores Altimmune’s focus on enhancing its communication with investors and stakeholders as it advances its clinical development programs.
Altimmune has recently taken part in industry conferences, including a fireside chat at the Citizens Life Sciences Conference in Miami Beach on March 10. The company also scheduled a fireside chat at the Leerink Global Healthcare Conference on March 11. These events focus on engaging with the investment community as Altimmune proceeds with clinical development.